Skandinaviska Enskilda Banken (SEB)’s Moderna MRNA Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $27.6K | Sell |
1,002
-65,453
| -98% | -$1.8M | ﹤0.01% | 814 |
|
2025
Q1 | $1.88M | Hold |
66,455
| – | – | 0.01% | 582 |
|
2024
Q4 | $2.62M | Sell |
66,455
-13,348
| -17% | -$525K | 0.01% | 527 |
|
2024
Q3 | $5.33M | Sell |
79,803
-165,884
| -68% | -$11.1M | 0.02% | 393 |
|
2024
Q2 | $29.1M | Buy |
245,687
+706
| +0.3% | +$83.8K | 0.14% | 122 |
|
2024
Q1 | $26.1M | Buy |
244,981
+736
| +0.3% | +$78.5K | 0.13% | 147 |
|
2023
Q4 | $24.3M | Sell |
244,245
-7,567
| -3% | -$753K | 0.14% | 140 |
|
2023
Q3 | $26M | Sell |
251,812
-52,345
| -17% | -$5.41M | 0.17% | 116 |
|
2023
Q2 | $37M | Sell |
304,157
-3,693
| -1% | -$449K | 0.24% | 88 |
|
2023
Q1 | $47.3M | Buy |
307,850
+59,310
| +24% | +$9.11M | 0.33% | 64 |
|
2022
Q4 | $44.6M | Sell |
248,540
-47,284
| -16% | -$8.49M | 0.34% | 74 |
|
2022
Q3 | $35M | Buy |
295,824
+25,128
| +9% | +$2.97M | 0.27% | 83 |
|
2022
Q2 | $38.7M | Buy |
270,696
+88,737
| +49% | +$12.7M | 0.28% | 75 |
|
2022
Q1 | $31.3M | Sell |
181,959
-29,788
| -14% | -$5.13M | 0.18% | 107 |
|
2021
Q4 | $53.3M | Sell |
211,747
-31,856
| -13% | -$8.01M | 0.27% | 77 |
|
2021
Q3 | $93.8M | Buy |
243,603
+103,910
| +74% | +$40M | 0.51% | 40 |
|
2021
Q2 | $32.8M | Buy |
139,693
+27,122
| +24% | +$6.37M | 0.2% | 110 |
|
2021
Q1 | $14.7M | Sell |
112,571
-21,602
| -16% | -$2.83M | 0.1% | 205 |
|
2020
Q4 | $14M | Buy |
134,173
+940
| +0.7% | +$98.2K | 0.1% | 195 |
|
2020
Q3 | $9.43M | Buy |
133,233
+14,496
| +12% | +$1.03M | 0.07% | 241 |
|
2020
Q2 | $7.63M | Buy |
118,737
+118,387
| +33,825% | +$7.6M | 0.06% | 261 |
|
2020
Q1 | $10K | Buy |
+350
| New | +$10K | ﹤0.01% | 902 |
|